Oak vs He & She MD
Oak advertises $119, $167 and $190; He & She MD advertises $99. None of the four is a sum anyone is ever billed.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Oak
Partner
$250/mo
The checkout charges $250 a month for compounded semaglutide and $300 for tirzepatide, not the lower figures the marketing pages advertise. That same checkout states the charge rises at each dose step, so the flat-price claim does not survive its own FAQ.
- No subscription and no automatic renewal charge, stated at checkout
- The dispensing pharmacy is named
- A real state list is published rather than a claim of nationwide coverage
- Compounded and branded priced side by side at checkout
- The flat-dose claim is contradicted by the checkout's own dose-step disclosure
- Each dose step is stated to add roughly $50 to $75
- Three entry figures across three pages, none of them matching the checkout
- $250 sits above the middle of this market before any escalation
Pick it for: Keeping your exposure to one fill while you titrate
Not for: Anyone choosing Oak for a price that holds as the dose climbs.
He & She MD
Partner
$99/mo
Every headline is an annual prepay: $99 a month for injectable semaglutide means $1,188 charged today, and $159 for tirzepatide means $1,908. The oral runs $199 for six months and renews above that.
- Every annual total is published in dollars
- $1,188 divides to an exact $99 month
- The oral renewal rate is disclosed
- Fifty states
- The $99 rate requires $1,188 at enrollment
- Tirzepatide asks $1,908 before the first dose
- The oral renews 20% above its opening rate
- Oral and injectable sit on different terms
Pick it for: Buyers who will not be shopping again this year
Not for: Anyone who needs to pay month by month.
Our verdict
Oak's three entry figures sit on three marketing pages and not one appears at checkout, so the number that brought you here is not a number Oak will take. He & She MD's $99 is honest arithmetic and still not a bill — a twelfth of one payment due before the first shipment, with no month-to-month rate behind it. And Oak's no-subscription promise has a limit: choose the three-month prescription and that one is billed upfront too.
What actually separates them
Oak and He & She MD state different things about published price and where you can use it. Everything else they publish, they publish the same way.
Oak costs $151 more than He & She MD — 153% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $1,188 at He & She MD against $3,000 at Oak — a difference of $1,812.
| Oak | He & She MD | |
|---|---|---|
| Published price | $250/mo | $99/mo |
| Where you can use it | US except WV and MS | 50 states |
Before you choose either
Whether these two publish a milligram dose is not settled in our records for both of them, so treat the two prices as not yet comparable and ask each what dose the monthly figure buys. Set the answers against every published price we hold — a lower monthly price at a smaller dose is not the cheaper option.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.